Zurich Cantonal Bank’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
31,890
-7
| -0% | -$152 | ﹤0.01% | 1453 |
|
|
2025
Q1 | $774K | Buy |
31,897
+3,244
| +11% | +$78.7K | ﹤0.01% | 1326 |
|
|
2024
Q4 | $598K | Buy |
28,653
+3,573
| +14% | +$74.6K | ﹤0.01% | 1521 |
|
|
2024
Q3 | $499K | Buy |
25,080
+388
| +2% | +$7.71K | ﹤0.01% | 1563 |
|
|
2024
Q2 | $382K | Hold |
24,692
| – | – | ﹤0.01% | 1671 |
|
|
2024
Q1 | $394K | Hold |
24,692
| – | – | ﹤0.01% | 1631 |
|
|
2023
Q4 | $415K | Hold |
24,692
| – | – | ﹤0.01% | 1626 |
|
|
2023
Q3 | $289K | Buy |
24,692
+5,044
| +26% | +$59K | ﹤0.01% | 1727 |
|
|
2023
Q2 | $264K | Hold |
19,648
| – | – | ﹤0.01% | 1734 |
|
|
2023
Q1 | $326K | Buy |
19,648
+4,425
| +29% | +$73.4K | ﹤0.01% | 1564 |
|
|
2022
Q4 | $283K | Buy |
15,223
+5,983
| +65% | +$111K | ﹤0.01% | 1607 |
|
|
2022
Q3 | $119K | Hold |
9,240
| – | – | ﹤0.01% | 2081 |
|
|
2022
Q2 | $65K | Sell |
9,240
-7,295
| -44% | -$51.3K | ﹤0.01% | 2475 |
|
|
2022
Q1 | $137K | Buy |
16,535
+8,258
| +100% | +$68.4K | ﹤0.01% | 2127 |
|
|
2021
Q4 | $56K | Buy |
8,277
+1,373
| +20% | +$9.29K | ﹤0.01% | 2702 |
|
|
2021
Q3 | $37K | Hold |
6,904
| – | – | ﹤0.01% | 2700 |
|
|
2021
Q2 | $40K | Hold |
6,904
| – | – | ﹤0.01% | 2498 |
|
|
2021
Q1 | $32K | Hold |
6,904
| – | – | ﹤0.01% | 2490 |
|
|
2020
Q4 | $23K | Hold |
6,904
| – | – | ﹤0.01% | 2565 |
|
|
2020
Q3 | $21K | Hold |
6,904
| – | – | ﹤0.01% | 2486 |
|
|
2020
Q2 | $32K | Hold |
6,904
| – | – | ﹤0.01% | 2342 |
|
|
2020
Q1 | $27K | Hold |
6,904
| – | – | ﹤0.01% | 2232 |
|
|
2019
Q4 | $26K | Hold |
6,904
| – | – | ﹤0.01% | 2430 |
|
|
2019
Q3 | $37K | Buy |
6,904
+595
| +9% | +$3.19K | ﹤0.01% | 2213 |
|
|
2019
Q2 | $24K | Buy |
+6,309
| New | +$24K | ﹤0.01% | 2411 |
|